You just read:

Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders

News provided by

Intec Pharma Ltd.

Jun 19, 2019, 07:00 ET